Beyond Air Inc. (XAIR) |
|
7.33 -0.45 (-5.78%)
|
01-19 08:07 |
|
Open: |
7.68 |
Pre. Close: |
7.78 |
|
High:
|
7.68 |
Low:
|
7.26 |
|
Volume:
|
621,764 |
Market Cap:
|
195M |
|
|
|
|
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.73 - 7.804 |
7.804 - 7.849 |
|
Low:
|
7.107 - 7.201 |
7.201 - 7.258 |
|
Close:
|
7.222 - 7.375 |
7.375 - 7.468 |
|
Technical analysis |
as of: 2022-01-18 4:35:27 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 10.92  One year: 12.43 |
| Support: |
Support1: 7.26 Support2: 6.04 |
| Resistance: |
Resistance1: 9.35 Resistance2: 10.64 |
| Pivot: |
8.79 |
| Moving Average: |
MA(5): 8.03 MA(20): 9.04
MA(100): 10.92 MA(250): 8.12  |
| MACD: |
MACD(12,26): -0.79 Signal(9): -0.72 |
| Stochastic oscillator: |
%K(14,3): 2.74 %D(3): 5.01 |
| RSI: |
RSI(14): 27.99 |
| 52-week: |
High: 16.41 Low: 4.62 Change(%): 16.5 |
| Average Vol(K): |
3-Month: 55797 10-Days: 33584 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.XAIR has closed below the lower band by 1.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 27.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 18 Jan 2022
Beyond Air (NASDAQ:XAIR) Cut to Sell at Zacks Investment Research - MarketBeat
Mon, 03 Jan 2022
Beyond Air, Inc. (NASDAQ:XAIR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Thu, 16 Dec 2021
Beyond Air: Follow The CEO And Buy The Dip - Seeking Alpha
Thu, 09 Dec 2021
Beyond Air, Inc. (XAIR) Announces Delay in Approval Timeline for LungFit PH - StreetInsider.com
Tue, 02 Nov 2021
Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference - Yahoo Finance
Wed, 06 Oct 2021
Why James 'Rev Shark' Deporre Likes Beyond Air - TheStreet
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
27 |
| Shares Float (M) |
23 |
|
% Held by Insiders
|
17.67 |
|
% Held by Institutions
|
17.54 |
|
Shares Short (K)
|
1,680 |
|
Shares Short P. Month (K)
|
1,680 |
Stock Financials |
|
EPS
|
-1.250 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
1.620 |
|
Profit Margin
|
|
|
Operating Margin
|
-7968.83 |
|
Return on Assets (ttm)
|
-37.3 |
|
Return on Equity (ttm)
|
-92.7 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.033 |
|
Sales Per Share
|
0.011 |
|
EBITDA (p.s.)
|
-0.870 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-20 |
|
Levered Free Cash Flow (M)
|
-10 |
Stock Valuations |
|
PE Ratio
|
-5.86 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.52 |
|
Price to Sales
|
663.76 |
|
Price to Cash Flow
|
-9.90 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2017-01-09 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
